Patents by Inventor Jörg Fritz

Jörg Fritz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINES COMPRISING AN IMMUNOSTIMULATORY PEPTIDE AND AN IMMUNOSTIMULATORY OLIGODEOXYNUCLEIC ACID MOLECULE
    Publication number: 20150010595
    Abstract: The invention refers to an improved vaccine against infections with pathogens, especially viral pathogens, comprising an antigen, a peptide of the formula R1—XZSZN—XZX—R2 and an immunostimulatory deoxynucleic acid containing deoxyinosine and/or deoxyuridine residues.
    Type: Application
    Filed: June 11, 2014
    Publication date: January 8, 2015
    Applicant: Valneva Austria GmbH
    Inventors: Michael Buschle, André Habel, Jörg Fritz, Karin Prinz, Karen Lingnau
  • Vaccine composition comprising an antigen and a peptide having adjuvant properties
    Patent number: 8900564
    Abstract: The invention relates to a vaccine which comprises at least one antigen and a peptide comprising a sequence R1—XZXZNXZX—R2, whereby N is a whole number between 3 and 7, preferably 5, X is a positively charged natural and/or non-natural amino acid residue, Z is an amino acid residue selected from the group consisting of L, V, I, F and/or W, and R1 and R2 are selected independently one from the other from the group consisting of —H, —NH2, —COCH3, —COH, a peptide with up to 20 amino acid residues or a peptide reactive group or a peptide linker with or without a peptide; X—R2 may also be an amide, ester or thioester of the C-terminal amino acid residue, as well as the use of said peptide for enhancing a patient's adaptive immune response to an antigen.
    Type: Grant
    Filed: May 21, 2008
    Date of Patent: December 2, 2014
    Assignee: Valneva Austria GmbH
    Inventors: Jörg Fritz, Frank Mattner, Wolfgang Zauner, Eszter Nagy, Michael Buschle
  • Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule
    Patent number: 8784837
    Abstract: The invention refers an improved vaccine against infections with pathogens, especially viral pathogens, comprising an antigen, a peptide of the formula R1—XZSZN—XZX—R2 and an immunostimulatory deoxynucleic acid containing deoxyinosine and/or deoxyuridine residues.
    Type: Grant
    Filed: April 13, 2010
    Date of Patent: July 22, 2014
    Assignee: Valneva Austria GmbH
    Inventors: Michael Buschle, André Habel, Jörg Fritz, Karin Prinz, Karen Lingnau
  • Vaccine composition comprising an antigen and a peptide having adjuvant properties
    Patent number: 8361476
    Abstract: The invention relates to a vaccine which comprises at least one antigen and a peptide comprising a sequence R1—XZXZNXZX—R2, whereby N is a whole number between 3 and 7, preferably 5, X is a positively charged natural and/or non-natural amino acid residue, Z is an amino acid residue selected from the group consisting of L, V, I, F and/or W, and R1 and R2 are selected independantly one from the other from the group consisting of —H, —NH2, —COCH3, —COH, a peptide with up to 20 amino acid residues or a peptide reactive group or a peptide linker with or without a peptide; X—R2 may also be an amide, ester or thioester of the C-terminal amino acid residue, as well as the use of said peptide for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: January 29, 2013
    Assignee: Intercell AG
    Inventors: Jörg Fritz, Frank Mattner, Wolfgang Zauner, Eszter Nagy, Michael Buschle
  • VACCINES
    Publication number: 20100297170
    Abstract: The invention refers an improved vaccine against infections with pathogens, especially viral pathogens, comprising an antigen, a peptide of the formula R1—XZSZN—XZX—R2 and an immunostimulatory deoxynucleic acid containing deoxyinosine and/or deoxyuridine residues.
    Type: Application
    Filed: April 13, 2010
    Publication date: November 25, 2010
    Inventors: Michael Buschle, André Habel, Jörg Fritz, Karin Prinz, Karen Lingnau
  • Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide
    Patent number: 7658928
    Abstract: Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
    Type: Grant
    Filed: November 29, 2007
    Date of Patent: February 9, 2010
    Assignee: Intercell AG
    Inventors: Jörg Fritz, Frank Mattner, Wolfgang Zauner, Michael Buschle, Alena Egyed